English
Specials
Premium
My Alerts
Moneycontrol

Abiomed

SYMBOL:ABMD|SECTOR:Health Care|DERIVED:CFD
i
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices are indicative only and not appropriate for trading purposes. Therefore Moneycontrol doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
$
2
2
0
0
.
1
1
8
8
3
3
0.23 (0.06%)

As on 22 Dec, 2022 | 02:29 IST

Day Range
380.51
381.26
LH
52 Week Range
219.85
381.99
LH
Advance Chart
Open380.77
Previous Close380.79
Beta1.16
High381.26
Low380.51
TTM EPS See historical trend   4.84(-3.78% YoY)
52 Week High381.99
52 Week Low219.85
TTM PE See historical trend    78.75(High PE)
Mkt. Cap ($ Billion)17.19
Dividend Yield--

Advanced Chart

*Delayed by 20 seconds

MC Technicals

Technical rating
i
This represents current trend.
Click here  for disclaimer.
Trend
Very Bullish
See Details  
Historical Rating  
Moving AveragesBullish
Technical IndicatorsBullish
Moving Averages CrossoversBullish

Pivot levels

TypeR1R2R3PPS1S2S3
Classic381.23 381.66 382.03380.86 380.43 380.06 379.63
Fibonacci381.17 381.36 381.66380.86 380.56 380.37 380.06
Camarilla380.86 380.94 381.01380.86 380.72 380.64 380.57

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Moving Averages
Days
5380.88
10380.63
20379.17
50343.63
100305.66
200291.26

Returns

Price Performance
1 Week0.28%
1 Month1.21%
3 Months50.77%
YTD6.13%
1 Year14.74%
3 Years134.00%

Financialsin million $

Peers

Peers Data Not Avaliable

Market news

Wall Street indexes hit record highs as oil falls with Strait of Hormuz declared open

April 18, 2026 8:35 AM
Show More

About the company

ABIOMED, Inc. is a provider of medical devices, which provides circulatory support and oxygenation. The Company develops, manufactures and markets its products, which are designed to improve blood flow and/or performing the pumping function of the heart. Its products are used in the cardiac catheterization lab (cath lab), by interventional cardiologists and in the heart surgery suite by cardiac surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures. Its operating segment includes the research, development and sale of medical devices to assist or replace the pumping function of the failing heart. Its existing products include Impella 2.5, Impella CP, Impella 5.0 and Impella LD. The Impella 2.5 device is a percutaneous micro heart pump with an integrated motor and sensors. The Impella CP device provides blood flow of approximately one liter more per minute than the Impella 2.5 device.